Search Results

first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors Neurocrine Biosciences

and Executive Management Team and the Approval of Change of Company Name to Nxera Pharma Neurocrine Biosciences

Industry News Sosei Heptares and Neurocrine Biosciences won Out-Licensing Deal of the Year from Locust

Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings Neurocrine Biosciences